Free Trial
NASDAQ:GENE

Genetic Technologies (GENE) Stock Price, News & Analysis

Genetic Technologies logo
$0.76 0.00 (0.00%)
As of 05/20/2025

About Genetic Technologies Stock (NASDAQ:GENE)

Key Stats

Today's Range
$0.77
$0.77
50-Day Range
$0.77
$0.77
52-Week Range
$0.67
$3.77
Volume
N/A
Average Volume
N/A
Market Capitalization
$3.37 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GENE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Genetic Technologies and its competitors with MarketBeat's FREE daily newsletter.

GENE Stock News Headlines

How to Collect Up To $5,917/mo From Trump’s Made In USA Boom
How to Collect Up To $5,917/mo From Trump's Made In USA Boom Thanks to President Trump's America-First policies, a historic wave of investment is flooding back into the United States: Apple committing a colossal $500 billion to build new U.S. factories. Microsoft injecting $80 billion into domestic manufacturing. Nvidia moving critical chip production back to America. But here's the hidden opportunity: There's now a groundbreaking way for you to start collecting monthly checks from these very same companies— checks that could reach as high as $5,917 each month. Don't miss your chance to participate directly in America's industrial comeback.
See More Headlines

GENE Stock Analysis - Frequently Asked Questions

Genetic Technologies' stock was trading at $0.7650 on January 1st, 2025. Since then, GENE stock has increased by 0.0% and is now trading at $0.7650.

Shares of Genetic Technologies reverse split before market open on Monday, December 4th 2023.The 1-5 reverse split was announced on Monday, December 4th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, December 4th 2023. An investor that had 100 shares of stock prior to the reverse split would have 20 shares after the split.

Shares of GENE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Genetic Technologies investors own include Netflix (NFLX), Plug Power (PLUG), Meta Platforms (META), OPKO Health (OPK), Nokia (NOK), Novavax (NVAX) and iBio (IBIO).

Company Calendar

Today
7/05/2025
Next Earnings (Estimated)
7/28/2025
Fiscal Year End
6/30/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological products, except diagnostic
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GENE
Employees
50
Year Founded
1989

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$7.66 million
Price / Cash Flow
N/A
Book Value
$0.25 per share
Price / Book
3.06

Miscellaneous

Free Float
4,534,000
Market Cap
$3.37 million
Optionable
Optionable
Beta
1.12

Social Links

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:GENE) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners